HP&M Files Comments Opposing FDA’s Proposed LDT Rule
FDA Law Blog
DECEMBER 6, 2023
FDA tries to justify the proposed rule by claiming that LDTs present significant risks, and that the solution is to regulate them all as medical devices. Part 11, the need to hire new laboratory personnel, and engage outside experts such as Contract Research Organizations, biostatisticians, lawyers, and software engineers.
Let's personalize your content